NMDAR antibody encephalitis overlapping with CLIPPERS syndrome in a psoriasis patient on adalimumab

J Neurol. 2021 Feb;268(2):714-716. doi: 10.1007/s00415-020-10341-4. Epub 2021 Jan 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab / adverse effects
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / complications
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / drug therapy
  • Humans
  • Psoriasis* / complications
  • Psoriasis* / drug therapy
  • Receptors, N-Methyl-D-Aspartate
  • Syndrome

Substances

  • Receptors, N-Methyl-D-Aspartate
  • Adalimumab